-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Leukemia, Diseases, Therapies, MDS, Pediatric, Biological Processes, white blood cells, Technology and Procedures, Young Adult, cytogenetics, Xenograft models, Lymphoid Malignancies, Study Population, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, molecular testing, NGS, RNA sequencing
Monday, December 7, 2020: 7:00 AM-3:30 PM

Grazia Fazio1*, Michela Bardini1*, Andrea Grioni1,2*, Paola De Lorenzo3*, Manuel Quadri1*, Lucia Pedace4*, Lilia Corral1*, Sonia Palamini1*, Barbara Buldini5*, Rosanna Parasole6*, Elena Barisone7*, Marco Zecca8*, Claudio Favre9*, Franco Locatelli, MD4*, Valentino Conter, MD10*, Carmelo Rizzari10*, Maria Grazia Valsecchi, PhD3,11*, Andrea Biondi, MD10 and Giovanni Cazzaniga, PhD1,12

1Tettamanti Research Center, Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
2CEITEC, Brno, Czech Republic
3Centro Operativo di Ricerca Statistica, Fondazione Tettamanti, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
4Pediatric Hemato-Oncology, IRCCS, Bambino Gesù Children’s Hospital, Sapienza, Univ of Rome, Rome, Italy
5Woman and Child Health Department, OncoHematology Lab, University of Padua, Padua, It, Italy
6Dept Pediatric Hemato-Oncology, Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon, Napoli, Italy, NAPOLI, Italy
7Divison of Pediatric Hematology and Oncology, Stem Cell Transplantation and Cellular Therapy, Regina Margherita Children's Hospital, Torino, Italy
8Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Dip. di Oncoematologia, Tumori pediatrici e Trapianto di cellule staminali, Azienda Ospedaliero-Universitaria Meyer, Florence, Italy
10Dept. Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
11Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy
12Genetics, Univ. Milan Bicocca, Monza, Italy

Linda Kachuri, PhD, MPH1*, Soyoung Jeon, BSc2*, Andrew T. DeWan, PhD3*, Catherine Metayer, MD, PhD4*, John S. Witte, Ph.D.1*, Xiaomei Ma, PhD5*, Charleston W. K. Chiang, PhD2*, Joseph L. Wiemels, PhD2* and Adam J de Smith, PhD2

1Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA
2Center for Genetic Epidemiology, Department of Preventive Medicine, University of Southern California, Los Angeles, CA
3Department of Chronic Diseases, Yale School of Public Health, Yale University, New Haven, CT
4School of Public Health, University of California Berkeley, Berkeley, CA
5School of Public Health, Yale University, New Haven, CT

Dabing Chen1*, Tingting Xiao1*, Dandan Lin1*, Haojie Zhu1*, Jingjing Xu1*, Xiaofeng Luo1*, Jinhua Ren1*, Zhihong Zheng1*, Zhizhe Chen1*, Jianda Hu, MD, PhD1 and Ting Yang, MD, PhD2

1Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2Department of Hematology, Fujian Medical University Union Hospital,Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, China

Lorenz Bastian1*, Sonja Hänzelmann1*, Martin Neumann1*, Alina Hartmann1*, Thomas Burmeister2*, Stefan Schwartz3*, Walter Fiedler, MD4, Mustafa Kondakci, MD5*, Andreas Viardot, Professor Dr6, Folker Schneller7*, Christoph Faul, MD8, Max S. Topp, MD9, Sören Franzenburg10*, Andre Franke10*, Heiko Trautmann, PhD1*, Nicola Goekbuget, MD11, Monika Brüggemann, MD1* and Claudia D Baldus, MD1*

1Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany
2Department of Hematology / Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany
3Department of Hematology and Oncology, Charité - Campus Benjamin Franklin, Berlin, Germany
4Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany
5Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
6Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
7Medical Department III, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
8University Hospital Tübingen, Tübingen, Germany
9Comprehensive Cancer Center Mainfranken and Department of Internal Medicine II, Division of Hematology and Medical Oncology, University Hospital Würzburg, Würzburg, Germany
10Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Kiel, Germany
11University Hospital, Department of Medicine II, Hematology/Oncology, Head of Study Center Depart of Medicine II, Hematology/Oncology Goethe University Hospital, Frankfurt, Germany

Yang Zhang, MD1, Fang Wang, MD1, Xue Chen, MD2*, Hong Liu, MD1*, Xiaoliang Wang, MD1*, Jiaqi Chen, MD1*, Panxiang Cao, MS1*, Xiaoli Ma, MD1* and Hongxing Liu, MD1,3,4

1Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
2Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Beijing, China
3Beijing Lu Daopei Institute of Hematology, Beijing, China
4Division of Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China

Laura N Eadie, BSc, PhD1,2*, Jacqueline Rehn, MSc(BioTech)1,2*, Susan L Heatley, PhD, MEd1,2*, Barbara J McClure, BSc, PhD1,2*, Caitlin Schutz Schutz, BSc (Hons)2*, James Breen, BSc, PhD1,3,4*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA1,2,5,6, David T Yeung, BSc, PhD, FRACP, FRCPA, MBBS1,2,5,6, Rosemary Sutton, BSc MSc PhD5,7* and Deborah L White, PhD, FFSc(RCPA)1,2,5,8

1Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia
2Cancer Program, Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
3Computational and Systems Biology Program, Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
4Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia
5Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, Australia
6Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
7Children's Cancer Institute Australia, University of NSW, Randwick, NSW, Australia
8Australian Genomics Health Alliance (AGHA), Parkville, VIC, Australia

Lucy E Cain, BSc, MBBS, MPH1, Oksana Mirochnik2*, Michael M Stevens, MBBS FRACP3*, Stewart J Kellie, MBBS FRACP MD MIntPH(Hons)3,4*, Bhavna Padhye, MBBS FRACP MClinTRes PhD3*, Steven J Keogh, MBBS(Hons) FRACP3*, Dinisha Govender, MBChB FRACP3*, Jessica Ryan, BMed(Hons) FRACP3*, Luciano Dalla-Pozza, MBBS FRACP3 and Caroline M Bateman, PhD, MBBS, FRACP, FRCPath, MRCP3,5

1Cancer Centre for Children, The Children's Hospital at Westmead, Potts Point, NSW, Australia
2Institute of Clinical Pathology and Medical Research (ICPMR) NSW Health Pathology, Westmead, NSW, Australia
3Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, NSW, Australia
4Discipline of Child and Adolescent Health, University of Sydney, Sydney, NSW, Australia
5Westmead Institute of Medical Research, Sydney, NSW, Australia

Margaux Camuset, MD1*, Alice Huault1*, Audrey Grain, MD1*, Beatrice Clemenceau, PhD2*, Fanny Rialland, MD3*, Caroline Thomas, M.D.4*, Patrice Chevallier, MD, PhD5,6, Marie-Christine Béné, PharmSciD, PhD5,7* and Marion Eveillard5,8*

1Pediatric department, Nantes University Hospital, Nantes, France
2CRCINA, Nantes University Hospital, Nantes, France
3Service Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, Nantes University Hospital, Nantes, France
4Pediatric Department, Nantes University Hospital, Nantes, FRA
5CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France
6Hematology Clinic, CHU Nantes, Nantes, France
7C.H.U. Hotel Dieu, Nantes, France
8Hematology Biology, Nantes University Hospital, Nantes, France

Xue Chen, MD1,2*, Fang Wang, MD2, Panxiang Cao, MS2*, Xiaoli Ma, MD2*, Lili Yuan, MD2*, Yang Zhang, MD2, Daijing Nie, MD2*, Jiaqi Chen, MD2*, Xiaosu Zhou2*, Ming Liu, MD2*, Zhixiu Liu, MD2*, Mingyue Liu2* and Hongxing Liu, MD2,3,4

1Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Beijing, China
2Division of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China
3Beijing Lu Daopei Institute of Hematology, Beijing, China
4Division of Laboratory Medicine, Beijing Lu Daopei Hospital, Beijing, China

*signifies non-member of ASH